{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:09:43Z","timestamp":1778735383004,"version":"3.51.4"},"reference-count":56,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Introduction: The management of resectable non-small cell lung cancer has long relied on a relatively limited set of determinants, primarily anatomical resectability and pathological stage. Although these parameters remain central to therapeutic planning, accumulating clinical and translational evidence indicates that they do not fully explain variability in outcomes observed after lung cancer surgery. The primary aim of this review is to evaluate whether current evidence supports the need for a novel heuristic framework in resectable NSCLC. Secondary aims are to examine how host-related, clinical, and data-driven factors contribute to prognosis and treatment selection beyond conventional staging systems. Methods: This review integrates evidence from clinical studies, national registries, and translational analyses to examine how these dimensions contribute to prognosis and treatment selection. Results: Over the past two decades, advances in surgical techniques, perioperative management, systemic therapies, and large-scale clinical databases have revealed additional determinants of prognosis beyond tumor burden, including physiological reserve, nutritional condition, systemic inflammatory state, comorbidities, and socioeconomic environment. Developments in multimodal strategies and minimally invasive surgery have reshaped the therapeutic landscape. Data-driven approaches have identified clinically meaningful subgroups not captured by conventional staging systems. Conclusions: A heuristic framework integrating tumor biology, patient characteristics, and treatment context may better reflect the complexity of contemporary thoracic oncology practice.<\/jats:p>","DOI":"10.3390\/curroncol33050245","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:12:31Z","timestamp":1777363951000},"page":"245","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8458-7109","authenticated-orcid":false,"given":"Lorenzo","family":"Gherzi","sequence":"first","affiliation":[{"name":"Thoracic Surgery Department, H\u00f4pital Cochin, APHP Centre, University of Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-1037","authenticated-orcid":false,"given":"Marco","family":"Alifano","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Department, H\u00f4pital Cochin, APHP Centre, University of Paris Cit\u00e9, 75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jtho.2020.09.012","article-title":"Lung Cancer in France","volume":"16","author":"Pujol","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100492","DOI":"10.1016\/j.lanepe.2022.100492","article-title":"Lung cancer trends and tumor characteristic changes over 20 years (2000\u20132020): Results of three French consecutive nationwide prospective cohorts\u2019 studies","volume":"22","author":"Debieuvre","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Alifano, M., Daffr\u00e9, E., Iannelli, A., Brouchet, L., Falcoz, P.E., Le Pimpec Barthes, F., Bernard, A., Pages, P.B., Thomas, P.A., and Dahan, M. (2021). The Reality of Lung Cancer Paradox: The Impact of Body Mass Index on Long-Term Survival of Resected Lung Cancer. A French Nationwide Analysis from the Epithor Database. Cancers, 13.","DOI":"10.3390\/cancers13184574"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.185.4157.1124","article-title":"Judgment under Uncertainty: Heuristics and Biases","volume":"185","author":"Tversky","year":"1974","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Forrest, L.F., Adams, J., Wareham, H., Rubin, G., and White, M. (2013). Socioeconomic inequalities in lung cancer treatment: Systematic review and meta-analysis. PLoS Med., 10.","DOI":"10.1371\/journal.pmed.1001376"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108798","DOI":"10.1016\/j.lungcan.2025.108798","article-title":"Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case re-view by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group","volume":"209","author":"Prisciandaro","year":"2025","journal-title":"Lung Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"00299-2022","DOI":"10.1183\/23120541.00299-2022","article-title":"What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling","volume":"9","author":"Evison","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lungcan.2023.01.008","article-title":"Reaching multidisciplinary consensus on the management of non-bulky\/non-infiltrative stage IIIA N2 non-small cell lung cancer","volume":"177","author":"Scherpereel","year":"2023","journal-title":"Lung Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e166S","DOI":"10.1378\/chest.12-2395","article-title":"Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Brunelli","year":"2013","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12672-022-00576-0","article-title":"Impact of sarcopenia on the prognosis and treatment of lung cancer: An umbrella review","volume":"13","author":"Lin","year":"2022","journal-title":"Discov. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110538","DOI":"10.1016\/j.ejso.2025.110538","article-title":"Sarcopenia and survival in surgically treated non-small cell lung cancer: A systematic review and meta-analysis","volume":"51","author":"Lading","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/0310057X0903700110","article-title":"Risk factors for post-pneumonectomy acute lung injury\/acute respiratory distress syndrome in primary lung cancer patients","volume":"37","author":"Jeon","year":"2009","journal-title":"Anaesth. Intensive Care"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mazzella, A., Mohamed, S., Maisonneuve, P., Borri, A., Casiraghi, M., Bertolaccini, L., Petrella, F., Lo Iacono, G., and Spaggiari, L. (2022). ARDS after Pneumonectomy: How to Prevent It? Development of a Nomogram to Predict the Risk of ARDS after Pneumonectomy for Lung Cancer. Cancers, 14.","DOI":"10.3390\/cancers14246048"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Daffr\u00e8, E., Prieto, M., Huang, H., Janet-Vendroux, A., Blanc, K., N\u2019Guyen, Y.L., Fournel, L., and Alifano, M. (2020). Normalized Pulmonary Artery Diameter Predicts Occurrence of Postpneumonectomy Respiratory Failure, ARDS, and Mortality. Cancers, 12.","DOI":"10.3390\/cancers12061515"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"St\u0119pkowski, M., Wojty\u015b, M.E., W\u00f3jcik, N., Safranow, K., Pier\u00f3g, J., Kordykiewicz, D., Szulc, J., Sulikowski, T., Jarosz, K., and Grodzki, T. (2025). Evaluation of Pulmonary Blood Flow, Right Atrium, Right Ventricle, and Pulmonary Artery in Patients After Pneumonectomy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14196793"},{"key":"ref_19","first-page":"817","article-title":"Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: Does the \u2018obesity paradox\u2019 really exist?","volume":"51","author":"Li","year":"2017","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.21037\/jtd-22-1835","article-title":"Obesity and lung cancer-a narrative review","volume":"15","author":"Vedire","year":"2023","journal-title":"J. Thorac. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.surg.2023.06.035","article-title":"Moving beyond frailty: Obesity paradox persists in lung resection","volume":"174","author":"Vadlakonda","year":"2023","journal-title":"Surgery"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clnesp.2021.12.026","article-title":"Associations between pretreatment nutritional assessments and treatment complications in patients with stage I-III non-small cell lung cancer: A systematic review","volume":"47","author":"Voorn","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ejcts\/ezy301","article-title":"Guidelines for enhanced recovery after lung surgery: Recommendations of the Enhanced Recovery After Surgery (ERAS\u00ae) Society and the European Society of Thoracic Surgeons (ESTS)","volume":"55","author":"Batchelor","year":"2019","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cllc.2025.09.014","article-title":"Late Survival and Hospital Trajectory After Pneumonectomy for Non-small Cell Lung Cancer","volume":"27","author":"Bouam","year":"2026","journal-title":"Clin. Lung Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/icvts\/ivab340","article-title":"Pneumonectomy for primary lung cancer: Contemporary outcomes, risk factors and model validation","volume":"34","author":"Brunswicker","year":"2022","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jtcvs.2017.10.151","article-title":"The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer","volume":"155","author":"Rogers","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ezae251","DOI":"10.1093\/ejcts\/ezae251","article-title":"Real-world outcomes of lobectomy, segmentectomy and wedge resection for the treatment of stage c-IA lung carcinoma","volume":"6","author":"Thomas","year":"2024","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jtho.2019.05.031","article-title":"Body Mass Index (BMI), BMI Change, and Overall Survival in Patients with SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium","volume":"14","author":"Shepshelovich","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ejso.2018.09.026","article-title":"Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis","volume":"45","author":"Deng","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2020.09.011","article-title":"Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study","volume":"149","author":"Fukumoto","year":"2020","journal-title":"Lung Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lungcan.2016.11.017","article-title":"Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)","volume":"104","author":"Lam","year":"2017","journal-title":"Lung Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/thorax-2023-220443","article-title":"Protective effect of height on long-term survival of resectable lung cancer: A new feature of the lung cancer paradox","volume":"79","author":"Porcher","year":"2024","journal-title":"Thorax"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/aje\/kwp088","article-title":"Height and site-specific cancer risk: A cohort study of a Korean adult population","volume":"170","author":"Sung","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1620\/tjem.251.51","article-title":"Association between Adult Height and Risk of Lung Cancer Incidence among Japanese Men: The Miyagi Cohort Study","volume":"251","author":"Mugikura","year":"2020","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e70049","DOI":"10.1002\/jcsm.70049","article-title":"Beyond Body Mass Index: The Impact of Height and Height-Normalised Weight on Overall Survival of Lung Cancer Undergoing Surgery","volume":"16","author":"Gherzi","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30840","DOI":"10.1038\/s41598-025-16443-1","article-title":"Risk prediction model for overall survival in lung cancer based on inflammatory and nutritional markers","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jtho.2016.01.015","article-title":"The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer","volume":"11","author":"Bremnes","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Abbass, T., Dolan, R.D., Laird, B.J., and McMillan, D.C. (2019). The Relationship between Imaging-Based Body Composition Analysis and the Systemic Inflammatory Response in Patients with Cancer: A Systematic Review. Cancers, 11.","DOI":"10.3390\/cancers11091304"},{"key":"ref_41","first-page":"100566","article-title":"Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: A French nationwide study from the Epithor cohort database","volume":"26","author":"Alifano","year":"2022","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2589-7500(20)30225-9","article-title":"A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: A multicentre, retrospective study","volume":"2","author":"Lu","year":"2020","journal-title":"Lancet Digit. Health"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rao, J., Yu, Y., Zhang, L., Wang, X., Wang, P., and Wang, Z. (2023). A nomogram for predicting postoperative overall survival of patients with lung squamous cell carcinoma: A SEER-based study. Front. Surg., 10.","DOI":"10.3389\/fsurg.2023.1143035"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Finke, I., Behrens, G., Weisser, L., Brenner, H., and Jansen, L. (2018). Socioeconomic Differences and Lung Cancer Survival-Systematic Review and Meta-Analysis. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00536"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"ezaf339","DOI":"10.1093\/ejcts\/ezaf339","article-title":"The Geographical Deprivation Index is Independently Associated with All-Cause Long-Term Mortality in Resectable Lung Cancer","volume":"67","author":"Petroncini","year":"2025","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_48","unstructured":"ClinicalTrials.gov (2026, March 01). A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients with Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030). ClinicalTrials.gov Identifier: NCT03456063, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03456063."},{"key":"ref_49","unstructured":"ClinicalTrials.gov (2026, March 01). Efficacy and Safety of Pembrolizumab (MK-3475) with Platinum Doublet Chemotherapy as Neoadjuvant\/Adjuvant Therapy for Participants with Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-Small Cell Lung Cancer (KEYNOTE-671). ClinicalTrials.gov Identifier: NCT03425643, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03425643."},{"key":"ref_50","unstructured":"ClinicalTrials.gov (2026, March 01). A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center International Study of Neoadjuvant\/Adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-Small Cell Lung Cancer (AEGEAN). ClinicalTrials.gov Identifier: NCT03800134, Available online: https:\/\/www.mdanderson.org\/patients-family\/diagnosis-treatment\/clinical-trials\/clinical-trials-index\/clinical-trials-detail.ID2019-0500.html?PageSpeed=noscript."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"ezae393","DOI":"10.1093\/ejcts\/ezae393","article-title":"Expanding the horizons of surgical research: Let us move towards P4 surgery","volume":"66","author":"Alifano","year":"2024","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gherzi, L., Daffr\u00e9, E., Prieto, M., Thomas, P.A., Le Pimpec-Barthes, F., Falcoz, P.E., Brouchet, L., Dahan, M., and Alifano, M. (2026). Clustering by patients-related characteristics identifies specific phenotypes with different prognosis after resection of non-small cell lung cancer: A French nationwide study from the Epithor database. Thorax, Online ahead of print.","DOI":"10.1136\/thorax-2025-224424"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.xjon.2024.06.010","article-title":"Glucose metabolism transcriptome clustering identifies subsets of resectable lung adenocarcinoma with different prognoses","volume":"20","author":"Alifano","year":"2024","journal-title":"JTCVS Open"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Leivaditis, V., Maniatopoulos, A.A., Lausberg, H., Mulita, F., Papatriantafyllou, A., Liolis, E., Beltsios, E., Adamou, A., Kontodimopoulos, N., and Dahm, M. (2025). Artificial Intelligence in Thoracic Surgery: A Review Bridging Innovation and Clinical Practice for the Next Generation of Surgical Care. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082729"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s13755-026-00449-8","article-title":"Enhancing LLM-based medical decision-making by test-time knowledge acquisition","volume":"14","author":"Li","year":"2026","journal-title":"Health Inf. Sci. Syst."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacr.2025.02.042","article-title":"Comparing Artificial Intelligence and Traditional Regression Models in Lung Cancer Risk Prediction Using A Systematic Review and Meta-Analysis","volume":"22","author":"Leonard","year":"2025","journal-title":"J. Am. Coll. Radiol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/5\/245\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:13:04Z","timestamp":1778731984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/5\/245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["curroncol33050245"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33050245","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]}}}